- Home
- RXST
RXST
RxSight Inc.
as 03-25-2025 12:37pm EST
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | ALISO VIEJO |
| Market Cap: | 1.0B | IPO Year: | 2021 |
| Target Price: | $49.33 | AVG Volume (30 days): | 615.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $24.09 - $66.54 | Next Earning Date: | 05-05-2025 |
| Revenue: | $139,927,000 | Revenue Growth: | 57.09% |
| Revenue Growth (this year): | 38.53% | Revenue Growth (next year): | 24.60% |
Stock Insider Trading Activity of RxSight Inc. (RXST)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fountain Tamara | RXST | Director | Mar 12 '25 | Sell | $25.71 | 7,000 | $180,001.50 | 24,793 | |
| Maniar Shweta | RXST | Director | Jan 22 '25 | Sell | $30.87 | 3,519 | $108,618.16 | 7,383 | |
| Corley Jesse Anderson | RXST | Director | Jan 15 '25 | Buy | $31.16 | 3,210 | $100,004.19 | 1,443 |
Latest RxSight Inc. News
RXST Breaking Stock News: Dive into RXST Ticker-Specific Updates for Smart Investing
MT Newswires
22 days ago
Top Premarket Gainers
Simply Wall St.
a month ago
RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$44.80 Price Target
Simply Wall St.
a month ago
RxSight Full Year 2024 Earnings: EPS Beats Expectations
GuruFocus.com
a month ago
RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Zacks
a month ago
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates
GlobeNewswire
a month ago
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
GuruFocus.com
a month ago
What To Expect From RxSight Inc (RXST) Q4 2024 Earnings
GlobeNewswire
a month ago
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
Compare RXST vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RXST RxSight Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.